Guidant Corp.

Recent Events

News & Analysis

guidant corp. and microsoft windows ce - All News and Analysis

• Guidant Receives European Approval for Drug Eluting Coronary Stent; Company Achieves CE Mark Approval Ahead of Schedule; XIENCE V Launch Slated for Second Quarter

  - 2006-01-30

  INDIANAPOLIS & BRUSSELS, Belgium -- Guidant Corporation (NYSE:GDT) today announced that the company has received Conformite Europeene CE Mark approval for the XIENCETM V Everolimus Eluting Coronary Stent System. This regulatory certification allows Guidant to begin marketing the drug eluting stent in the 25 countries of the European Union. In...

  Tags: Guidant Corp., Microsoft Windows CE

• Guidant Receives Recommendation for Approval from European Competent Authority for Drug Eluting Stent; Company Has Successfully Completed Conformity Assessment and Facility Audit by Notified Body; CE Mark Certificate Expected in 7-10 Days

  - 2006-01-24

  INDIANAPOLIS & BRUSSELS, Belgium -- Guidant Corporation (NYSE:GDT) today announced that the company's XIENCETM V Everolimus Eluting Coronary Stent System has been recommended for approval by its European Competent Authority. In addition, the company has successfully completed the Conformity Assessment process and facility audit by its European Notified Body. Guidant...

  Tags: audit, Guidant Corp., Microsoft Windows CE

• Guidant Prepared to Launch Heart Failure Devices Outside the United States; CE Mark Clears Way for Guidant to Reenter Market

  - 2005-07-25

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) said today that it received Conformite Europeenne CE Mark approval to launch its CONTAK RENEWAL 4 cardiac resynchronization therapy defibrillators for use outside the United States. The company had voluntarily removed devices from implant and distribution last month. After further testing and evaluation of the...

  Tags: Guidant Corp., Microsoft Windows CE

• Guidant Receives CE Mark Approval for the MULTI-LINK VISION Cobalt Chromium Coronary Stent System; New Technology Demonstrates Excellent Clinical Results

  - 2002-12-19

  Business Editors, Health & Medical Writers

  Tags: Guidant Corp., Microsoft Windows CE

• Guidant Announces FDA Clearance and CE Mark of Next Generation Heart Failure Lead Delivery System; New System Enhances Physician's Ability to Navigate Challenging Anatomy

  - 2002-08-28

  Business Editors and Health/Medical Writers

  Tags: FDA, Guidant Corp., Microsoft Windows CE, physician

• Guidant Announces CE Mark Approval of Next Generation Lead for Use with Heart Failure Devices; Innovative Lead Instrumental in Delivering Therapy for Heart Failure Patients

  - 2002-02-27

  Business & Health/Medical Editors

  Tags: Guidant Corp., Microsoft Windows CE, therapy

• Guidant Announces Filing for European Approval to Market Drug Eluting Stent; ACHIEVE CE Mark Filing Represents Milestone in Guidant's Drug Eluting Stent Efforts

  - 2002-02-01

  Business & Health/Medical Editors

  Tags: Guidant Corp., Microsoft Windows CE

• Guidant Announces CE Mark Approval and First Implants of Advanced Pacemaker System; New Pacemaker Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features

  - 2001-10-09

  Business Editors and Health/Medical Writers

  Tags: Guidant Corp., Microsoft Windows CE, patient

• First Patients Treated With Guidant's Drug-Eluting Stent; Clinical Trial Will Be Basis for CE Mark Approval of MULTI-LINK TETRA-D Stent

  - 2001-05-24

  Business Editors and Health/Medical Writers

  Tags: clinical trial, Guidant Corp., Microsoft Windows CE

• Guidant Announces CE Mark Approval and First European Implant of Next-Generation Heart Failure Technology

  - 2001-05-23

  Business Editors, Health/Medical Writers

  Tags: Guidant Corp., Microsoft Windows CE